CClinicalTrials.gg
Not yet recruitingNCT06538363ROIPFUpdated Aug 5, 2024

Running Online Injury Prevention Feasibility Study

An interventional study of Education and Generic Education in Musculoskeletal Injury, sponsored by Simon Fraser University. Not yet recruiting at 1 site in Canada. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-05.

Sponsored by Simon Fraser University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The main purpose of this study is to test the feasibility of a larger scale interventional study. The investigators want to understand whether data can be reliably collected data various different streams while participants follow a standard 12-week half-marathon training program, and whether participants follow training recommendations.

Read the detailed description

Research procedures will include an online eligibility questionnaire, a demographic intake questionnaire, a weekly injury questionnaire, and an exit questionnaire (hosted on the SFU Survey Monkey platform). This study involves an initial in-person 1-hour orientation session. Multiple dates will be offered in order to accommodate participants. Participants will be randomly allocated to either the control or intervention group. All participants will be given a pair of running shoes (Hettas Sport Ltd.). Half of the participants in each group will also be outfitted with a pair of shoe-embedded sensors (Plantiga Technologies, Inc.). All participants will also be given access to a menstrual cycle tracking app (MyNormative). If participants have a Strava profile already, this will be linked to the study third-party data extraction API called "Strava API" to give the research team access to select workout data. If participants do not have a Strava profile, an anonymous profile will be created and linked to the API. Participants will be oriented on how to use the shoe-embedded sensors and MyNormative app. Following a one to two week familiarization period in which the participants can become comfortable with the protocol, participants will commence a 12-week half-marathon training program guided by a coach. The training program will consist of four runs per week, including two optional in-person group runs, and will culminate with a half-marathon race. Over the course of the training program, participants will be responsible for uploading the data from the shoe-embedded sensors after each run (for those that have them), tracking their menstrual cycle with the MyNormative app, and recording their runs with their GPS-enabled smartwatch which will automatically upload training data to Strava. Participants in the intervention group will be given individualized training recommendations based on their training data uploaded to Strava (e.g., "Training load is high, take a rest day tomorrow" or "Training load is appropriate, continue as planned"). Training load will be calculated from average distance, speed, step count, and heart rate. Participants in the control group will receive generic training recommendations (e.g., "Keep up the good work" or "Make sure to balance training with enough recovery time"). Communication with the participants will occur via text message on their personal cell phone. Following completion of the study, participants in the intervention group will be asked to complete an online questionnaire about why the participants did/did not follow the individualized training advice. Participants will be permitted to keep the running shoes but will be required to return the shoe-embedded sensors at study completion.

02

Conditions studied

  • Musculoskeletal Injury

Browse trials for

Keywords

  • Running
  • Wearable sensors
  • Biomechanics
  • Training
  • Education
  • Female athlete
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Cis-gender female (someone who was born female and currently identifies as a woman) runners
  • Over the age of 18
  • Have not been injured in the last 3 months (**For the purpose of this study, an injury is defined as "musculoskeletal (originating from the bones, muscles, joints) that has restricted the ability to run in any way (distance, speed, duration) for at least 7 days or for 3 consecutive training sessions"**)
  • Have run on average 3 times/week for the last 6 months
  • Own a GPS-enabled smart watch with an optical wrist heart rate sensor
  • Fit shoe size between 6.5 and 8.5 US women's sizing
  • Able to attend one of the in-person orientation sessions
  • Able to understand written and spoken English

Exclusion criteria

Exclusion Criteria:

  • Any current pain with running
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Control

    Behavioral: Generic Education

  • Experimental
    Intervention

    Behavioral: Education

Interventions

  • BehavioralEducation

    Personalized training advice

  • BehavioralGeneric Education

    Generic training advice

05

What researchers measure

Primary outcomes

  1. Recruitment Rate

    - The number of participants enrolled versus the target number.

    Time frame: 4 weeks

  2. Data Collection Compliance

    * The percentage of participants who complete the online eligibility questionnaire, demographic intake questionnaire, weekly injury questionnaire, and exit questionnaire. * The percentage of participants who reliably upload data from the shoe-embedded sensors after each run. * The percentage of participants who consistently track their menstrual cycle with the MyNormative app. * The percentage of participants who regularly record their runs with their GPS-enabled smartwatch and upload data to Strava.

    Time frame: 12 weeks

  3. Attendance

    - Attendance rate at the initial in-person orientation session and optional in-person group runs.

    Time frame: 16 weeks

  4. Adherence to Training Recommendations

    - Percentage of participants in the intervention group who follow the individualized training recommendations.

    Time frame: 12 weeks

  5. Training Program Compliance

    - Percentage of completed prescribed training runs per week during the 12-week half-marathon training program.

    Time frame: 12 weeks

  6. Satisfaction and Usability

    * Participant feedback on the ease of use and satisfaction with the shoe-embedded sensors, MyNormative app, and Strava integration. Measured during the exit questionnaire. * Participant feedback on the clarity and usefulness of the training recommendations (both individualized and generic). Measured during the exit questionnaire.

    Time frame: 12 weeks

  7. Barriers and Facilitators

    - Reasons provided by participants in the intervention group for following or not following the individualized training advice, as captured in the exit questionnaire.

    Time frame: 12 weeks

Secondary outcomes

  1. Injury incidence

    - Incidence and severity of running-related injuries reported weekly via the injury questionnaire. Injuries are defined according to the consensus definition of running injuries by Yamato et al ("musculoskeletal (originating from the bones, muscles, joints) that has restricted your ability to run in any way (distance, speed, duration) for at least 7 days or for 3 consecutive training sessions").

    Time frame: 12 weeks

06

Study locations

1 site
  • Simon Fraser University
    Burnaby, British Columbia V5A 1S6, Canada
07

References and documents

Publications

  • Yamato TP, Saragiotto BT, Lopes AD. A consensus definition of running-related injury in recreational runners: a modified Delphi approach. J Orthop Sports Phys Ther. 2015 May;45(5):375-80. doi: 10.2519/jospt.2015.5741. Epub 2015 Mar 26. PubMed 25808527 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT06538363
Lead sponsor
Simon Fraser University
Collaborators
Natural Sciences and Engineering Research Council, Canada
Responsible party
Chris Napier (Assistant Professor, Simon Fraser University) — Principal investigator
First posted
Aug 5, 2024
Start date
Aug 1, 2024 (estimated)
Primary completion
Jan 1, 2025 (estimated)
Completion
Jan 1, 2025 (estimated)
Last update
Aug 5, 2024

Study contacts

Chris Napier, PhD
Contact
cnapier@sfu.ca
6047211310
Patrick Mayerhofer, PhD
Contact
patrick_mayerhofer@sfu.ca
Chris Napier, PhD
principal investigator · Simon Fraser University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion